Jim Cramer on DaVita: "Haven't Seen That Stock Do That Well In This Long"

DaVita Inc. (NYSE:DVA) is one of the S&P 500 stocks that Jim Cramer shared his take on. Cramer highlighted the reason for the company’s rally in February, as he said:

Now, there were a couple non-data center stories, too. The third-best performer in the S&P last month was DaVita. It’s a medical technology company, best known for its kidney dialysis machines. It had a terrible year in 2025, down 24%, but they reported a terrific quarter last month, and the stock caught fire, which is how it finished February up 43%. Haven’t seen that stock do that well in this long. As was the case with Dell, I think this was a situation where the analysts and the investors simply got too negative about the story. So when it turned out that things weren’t as bad as they thought, the stock soared.

DaVita Inc. (NYSE:DVA) delivers kidney dialysis treatment through outpatient centers, hospitals, and home-based care, supported by laboratory testing and physician services.